On May 5, 2023, Theralink Technologies, Inc. appointed Andrew Kucharchuk, a member of the Board of Directors of the Company, as its Chief Financial Officer, effective May 8, 2023. Mr. Kucharchuk was previously the Chief Executive Officer and Chief Financial Officer of OncBioMune Pharmaceuticals, Inc., the Company's predecessor. On May 5, 2023, the Company terminated the employment of Thomas Chilcott, effective immediately.

Mr. Chilcott previously served as the Company's Chief Financial Officer, Treasurer and Secretary.